Correlation Between Candel Therapeutics and Aura Biosciences
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Aura Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Aura Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Aura Biosciences, you can compare the effects of market volatilities on Candel Therapeutics and Aura Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Aura Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Aura Biosciences.
Diversification Opportunities for Candel Therapeutics and Aura Biosciences
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Candel and Aura is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Aura Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aura Biosciences and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Aura Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aura Biosciences has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Aura Biosciences go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Aura Biosciences
Given the investment horizon of 90 days Candel Therapeutics is expected to generate 2.23 times more return on investment than Aura Biosciences. However, Candel Therapeutics is 2.23 times more volatile than Aura Biosciences. It trades about -0.01 of its potential returns per unit of risk. Aura Biosciences is currently generating about -0.17 per unit of risk. If you would invest 887.00 in Candel Therapeutics on December 27, 2024 and sell it today you would lose (137.00) from holding Candel Therapeutics or give up 15.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Candel Therapeutics vs. Aura Biosciences
Performance |
Timeline |
Candel Therapeutics |
Aura Biosciences |
Candel Therapeutics and Aura Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Candel Therapeutics and Aura Biosciences
The main advantage of trading using opposite Candel Therapeutics and Aura Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Aura Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aura Biosciences will offset losses from the drop in Aura Biosciences' long position.Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Aura Biosciences vs. Aerovate Therapeutics | Aura Biosciences vs. Adagene | Aura Biosciences vs. Acrivon Therapeutics, Common | Aura Biosciences vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Equity Valuation Check real value of public entities based on technical and fundamental data |